5 key compounds

Hormonal & Sexual Health Peptides

Hormonal and sexual health peptides modulate the hypothalamic-pituitary-gonadal (HPG) axis and related systems. These compounds are studied for reproductive endocrinology, sexual function disorders, and hormonal balance research.

EndocrineReproductiveSexual FunctionHPG Axis
5
Key compounds documented
HPG
Primary axis targeted
PT-141
Most studied compound
FDA
Bremelanotide approved

Overview

The HPG axis is a complex endocrine feedback system that regulates reproductive hormones. Peptides that interact with this system have significant research implications for conditions ranging from hypogonadism to sexual dysfunction.

PT-141 (Bremelanotide) works through melanocortin receptors, unlike phosphodiesterase inhibitors. Its unique mechanism of action — working centrally rather than peripherally — makes it particularly interesting for research into the neural basis of sexual desire. It received FDA approval in 2019 for premenopausal women with HSDD.

Kisspeptin represents a fundamental regulator of GnRH neurons and the HPG axis. Research into kisspeptin signaling has revolutionized understanding of puberty onset, reproductive seasonality, and the neuroendocrine control of fertility.

Key Compounds

PT-141 (Bremelanotide)

MC4R agonist

Melanocortin receptor agonist that activates MC3R and MC4R. FDA-approved for HSDD in premenopausal women. Studied for male sexual dysfunction as well.

Sexual desireCentral actionFDA approved

Kisspeptin-10

GnRH trigger

The 10-amino acid active fragment of kisspeptin. Potent stimulator of GnRH release, used in research on puberty, fertility, and HPG axis function.

GnRH releaseFertility researchHPG axis

Gonadorelin

GnRH

Synthetic GnRH. Used clinically to assess HPG axis function and in fertility treatments. Pulsatile administration stimulates LH and FSH; continuous suppresses.

LH/FSH releaseFertilityDiagnostic

Triptorelin

GnRH agonist

Long-acting GnRH agonist that, with continuous use, downregulates GnRH receptors. Used in prostate cancer, endometriosis, and precocious puberty.

HPG suppressionClinical useLong-acting

Leuprolide

GnRH agonist

FDA-approved GnRH agonist used in multiple clinical conditions. One of the most extensively studied compounds in this class.

FDA approvedMultiple indicationsWell-studied

Mechanism of Action

1

Hypothalamic-Pituitary Signaling

GnRH peptides bind to receptors in the pituitary, controlling release of LH and FSH which regulate gonadal function.

2

Melanocortin Receptor Activation

MC3R and MC4R in the CNS mediate central effects on sexual desire and arousal through dopaminergic and serotonergic pathways.

3

Kisspeptin-GnRH Cascade

Kisspeptin neurons in the hypothalamus serve as master regulators of GnRH pulsatility, integrating metabolic, environmental, and reproductive signals.

4

Receptor Desensitization

Continuous GnRH agonist exposure paradoxically suppresses the HPG axis through receptor downregulation, a mechanism exploited clinically.

Research Applications

🔬

Reproductive Endocrinology

Research into fertility disorders, hypogonadism, and HPG axis dysregulation.

💊

Sexual Medicine Research

Studying mechanisms and treatments for hypoactive sexual desire disorder and erectile dysfunction.

🧬

Oncology Research

GnRH agonists extensively studied for hormone-sensitive cancers like prostate and breast cancer.

🧒

Puberty Research

Kisspeptin research advancing understanding of puberty timing and central precocious puberty.

⚠️

Research Information Only

This content is provided for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. Always consult a qualified healthcare professional before making any health-related decisions.